Generic Kaftrio 37.5mg/25mg/50mg tablets
NHS hospitals in England used £51,251,200 of indicative cost of Generic Kaftrio 37.5mg/25mg/50mg tablets in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is down 21.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Generic Kaftrio 37.5mg/25mg/50mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Generic Kaftrio 37.5mg/25mg/50mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Alder Hey Childrens Nhs Foundation Trust | £5,890,401 |
| Guy's & St Thomas' Nhs Foundation Trust | £5,333,286 |
| Manchester University Nhs Ft | £4,765,737 |
| Oxford University Hospitals Nhs Ft | £3,163,248 |
| Univ Hpls Bristol Nhs Foundation Trust | £2,696,302 |
| University Hospital Southampton Nhs Ft | £2,512,236 |
| Cambridge Univ Hosp Nhs Foundation Trust | £2,462,159 |
| King's College Hpl Nhs Foundation Trust | £2,420,427 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £2,395,388 |
| Sheffield Children's Nhs Ft | £2,186,731 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.